Taylor Hoffman Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$391K Sell
1,336
-3
-0.2% -$986 0.12% 91
2025
Q4
$469K Sell
1,339
-13
-1% -$4.39K 0.14% 82
2025
Q3
$437K Sell
1,352
-8
-0.6% -$2.49K 0.14% 87
2025
Q2
$529K Sell
1,360
-30
-2% -$12.1K 0.18% 75
2025
Q1
$601K Hold
1,390
0.22% 66
2024
Q4
$513K Sell
1,390
-38
-3% -$15.9K 0.19% 74
2024
Q3
$579K Buy
+1,428
New +$763K 0.22% 68

Other funds holding ELV

Taylor Hoffman Capital Management's ELV Position: Q1 2026 in Review

Taylor Hoffman Capital Management reduced its Elevance Health (ELV) stake by 0.22% in Q1 2026, selling an estimated $986 and leaving 1,336 shares worth $391K. The position accounts for 0.12% of the portfolio, ranked #91.

Taylor Hoffman Capital Management first reported a position in ELV in Q3 2024 and has held it in 7 quarters since. The position peaked at $601K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Taylor Hoffman Capital Management held 1,336 shares of Elevance Health worth $391K as of Q1 2026.
  • Taylor Hoffman Capital Management sold 3 Elevance Health shares in Q1 2026, an estimated $986.
  • Elevance Health made up 0.12% of Taylor Hoffman Capital Management's portfolio in Q1 2026, its #91 holding.
  • Taylor Hoffman Capital Management first reported a position in Elevance Health in Q3 2024 and has held it in 7 quarters since.
  • Taylor Hoffman Capital Management's Elevance Health position peaked at $601K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Taylor Hoffman Capital Management's 13F filing for Q1 2026, filed 13 May 2026.